Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.52)
# 1,061
Out of 4,630 analysts
598
Total ratings
46.9%
Success rate
10.4%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintained: Buy | $46 | $23.54 | +95.41% | 33 | Aug 7, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | $38 → $35 | $15.85 | +120.82% | 5 | Aug 7, 2026 | |
| OABI OmniAb | Reiterated: Buy | $9 | $3.08 | +192.21% | 11 | Aug 7, 2026 | |
| EXEL Exelixis | Maintained: Hold | $47 → $51 | $54.07 | -5.68% | 55 | Aug 6, 2026 | |
| ABCL AbCellera Biologics | Maintained: Buy | $8 → $9 | $6.93 | +29.87% | 19 | Aug 6, 2026 | |
| LYEL Lyell Immunopharma | Initiated Coverage: Buy | $36 | $14.71 | +144.73% | 1 | Aug 6, 2026 | |
| CBIO Crescent Biopharma | Maintained: Buy | $30 → $28 | $16.84 | +66.27% | 18 | Jul 31, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $111 | $77.33 | +43.54% | 11 | Jul 31, 2026 | |
| INCY Incyte | Maintained: Buy | $123 → $145 | $120.56 | +20.27% | 40 | Jul 28, 2026 | |
| MGNX MacroGenics | Maintained: Hold | $4 | $4.04 | -0.99% | 35 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $131.10 | +52.56% | 30 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $20.40 | +125.49% | 8 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 | $92.78 | +88.62% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $10.59 | +107.74% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $40 | $25.53 | +56.68% | 30 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $3.73 | +114.48% | 6 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.15 | +179.07% | 13 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $2.41 | +356.43% | 25 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $28.06 | +63.93% | 14 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $23.67 | +68.99% | 24 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $7.24 | +134.81% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $4.64 | +61.64% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $6.67 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $4.05 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $1.48 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $27.12 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $2.41 | n/a | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $0.9075 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $6.16 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $0.74 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1 | $0.668 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $1.26 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $2.47 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $63.36 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 | $4.12 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $219.20 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $63.81 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $56.56 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $16 | $20.51 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.000001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $12.53 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.87 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $8.85 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $256.56 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.65 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $4.63 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $40.17 | n/a | 2 | Apr 8, 2013 |
Zymeworks
Aug 7, 2026
Maintained: Buy
Price Target: $46
Current: $23.54
Upside: +95.41%
Janux Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $38 → $35
Current: $15.85
Upside: +120.82%
OmniAb
Aug 7, 2026
Reiterated: Buy
Price Target: $9
Current: $3.08
Upside: +192.21%
Exelixis
Aug 6, 2026
Maintained: Hold
Price Target: $47 → $51
Current: $54.07
Upside: -5.68%
AbCellera Biologics
Aug 6, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $6.93
Upside: +29.87%
Lyell Immunopharma
Aug 6, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $14.71
Upside: +144.73%
Crescent Biopharma
Jul 31, 2026
Maintained: Buy
Price Target: $30 → $28
Current: $16.84
Upside: +66.27%
Disc Medicine
Jul 31, 2026
Maintained: Buy
Price Target: $111
Current: $77.33
Upside: +43.54%
Incyte
Jul 28, 2026
Maintained: Buy
Price Target: $123 → $145
Current: $120.56
Upside: +20.27%
MacroGenics
Jul 24, 2026
Maintained: Hold
Price Target: $4
Current: $4.04
Upside: -0.99%
Jul 17, 2026
Maintained: Buy
Price Target: $200
Current: $131.10
Upside: +52.56%
Jul 15, 2026
Maintained: Buy
Price Target: $46
Current: $20.40
Upside: +125.49%
Jul 15, 2026
Maintained: Buy
Price Target: $175
Current: $92.78
Upside: +88.62%
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $10.59
Upside: +107.74%
Jul 10, 2026
Rated: Buy
Price Target: $34 → $40
Current: $25.53
Upside: +56.68%
Jul 2, 2026
Maintained: Buy
Price Target: $8
Current: $3.73
Upside: +114.48%
Jun 1, 2026
Maintained: Buy
Price Target: $6
Current: $2.15
Upside: +179.07%
May 13, 2026
Maintained: Buy
Price Target: $11
Current: $2.41
Upside: +356.43%
May 12, 2026
Maintained: Buy
Price Target: $48 → $46
Current: $28.06
Upside: +63.93%
Apr 8, 2026
Maintained: Buy
Price Target: $40
Current: $23.67
Upside: +68.99%
Mar 18, 2026
Maintained: Buy
Price Target: $17
Current: $7.24
Upside: +134.81%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $4.64
Upside: +61.64%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $6.67
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $4.05
Upside: n/a
Mar 12, 2025
Maintained: Buy
Price Target: $4
Current: $1.48
Upside: n/a
Nov 15, 2024
Maintained: Buy
Price Target: $4
Current: $27.12
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $4
Current: $2.41
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $7 → $6
Current: $0.9075
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $6.16
Upside: n/a
May 13, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $0.74
Upside: n/a
May 11, 2022
Maintained: Hold
Price Target: $3 → $1
Current: $0.668
Upside: n/a
Mar 12, 2021
Maintained: Buy
Price Target: $25 → $27
Current: $1.26
Upside: n/a
Mar 11, 2021
Maintained: Hold
Price Target: $6
Current: $2.47
Upside: n/a
Mar 29, 2019
Maintained: Buy
Price Target: $18 → $21
Current: $63.36
Upside: n/a
Mar 14, 2019
Maintained: Hold
Price Target: $160
Current: $4.12
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $219.20
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $63.81
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $56.56
Upside: n/a
Apr 27, 2018
Maintained: Hold
Price Target: $17 → $16
Current: $20.51
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.000001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $12.53
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $1.87
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $8.85
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $256.56
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $6.65
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $4.63
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $40.17
Upside: n/a